Baidu
map

NEJM:心脏手术后房颤:控制心率or节律?

2016-04-15 MedSci MedSci原创

心脏手术后房颤增加了死亡,并发症和住院率。哪些术后房颤患者病情稳定,最好的初始治疗策略是什么?-心率或节律控制-仍存在争议。新发术后房颤患者被随机分配接受心率控制或节律控制。主要终点是随机分组后60天之内总住院天数,由Wilcoxon秩和检验评定。术前招募的2109例患者中,术后房颤发生695例(33.0%);这些患者中,523例接受随机分组。心率控制组和节律控制组的总住院天数是相似的(平均分别为

心脏手术后房颤增加了死亡率,并发症和住院时间。术后病情稳定的房颤患者中,最好的初始治疗策略是什么?应该控制心率还是控制节律?这些仍存在争议。

研究人员进行了一项随机对照研究,将新发术后房颤患者被随机分配到接受心率控制或节律控制。主要终点是随机分组后60天之内总住院天数,由Wilcoxon秩和检验评定。

术前招募的2109例患者中,术后房颤发生695例(33.0%);这些患者中,523例接受随机分组。心率控制组和节律控制组的总住院天数是相似的(平均分别为5.1天和5.0天,P=0.76)。死亡率(P=0.64)或总的严重不良事件(心率控制组为每100名患者-月发生24.8例,节律控制组为每100名患者-月发生26.4例,P=0.61)没有显著组间差异,其中包括血栓和出血事件。每组约有25%的患者从分配的治疗中偏离,主要是药物无效(心率控制组)或胺碘酮副作用或药物不良反应(节律控制组)导致的结果。在60天时,心率控制组中93.8%的患者和节律控制组中97.9%的患者有稳定的心律,而且在前30天时没有发生房颤(P=0.02),分别有84.2%和86.9%的患者从出院后到60天时没有发生房颤(P=0.41)。

控制心率和控制节律对于治疗心脏手术后房颤,有相等的住院天数,以及类似的并发症发生率,且发病后60天持续性房颤降低的比率都是相似的。没有一种治疗策略显示出较另一种有额外的临床优势。

原始出处:

A. Marc Gillinov,Emilia Bagiella,Alan J. Moskowitz,et al.Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery,NEJM,2016.4.4

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2066831, encodeId=f1302066831d7, content=<a href='/topic/show?id=fe1a6106394' target=_blank style='color:#2F92EE;'>#术后房颤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61063, encryptionId=fe1a6106394, topicName=术后房颤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a22500182, createdName=1696533704_45270454, createdTime=Mon Jun 20 10:22:00 CST 2016, time=2016-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82698, encodeId=00e68269865, content=这个是短期的效果,长期效果呢,对于持续性房颤,节律控制优于心率控制哦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ebb1716792, createdName=黑心天使, createdTime=Mon Apr 25 11:23:00 CST 2016, time=2016-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79712, encodeId=2b4ae9712a2, content=文章值得一读!, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xwU6047w4GQZHmaJMe3cGxCqPS0x43a9R04dN3HrAn5diaR2N4pEwoibqiaiaA3m6ia3g3XbZXadIomlRa5WAvjSUHb/0, createdBy=93aa1715091, createdName=为啥子, createdTime=Tue Apr 19 21:05:00 CST 2016, time=2016-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78780, encodeId=5447e87805a, content=文章不错,看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160416/IMG5712156C1448C6881.jpg, createdBy=24d11713519, createdName=愤怒骆驼, createdTime=Sat Apr 16 18:39:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78733, encodeId=4803e8733d1, content=学习了,点赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a411691127, createdName=1de5aaa9m95(暂无匿称), createdTime=Sat Apr 16 14:27:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78618, encodeId=cfd6e8618d1, content=关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Fri Apr 15 21:44:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78553, encodeId=0942e85532d, content=文章不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Fri Apr 15 20:04:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78554, encodeId=dd42e855499, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Fri Apr 15 20:04:00 CST 2016, time=2016-04-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2066831, encodeId=f1302066831d7, content=<a href='/topic/show?id=fe1a6106394' target=_blank style='color:#2F92EE;'>#术后房颤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61063, encryptionId=fe1a6106394, topicName=术后房颤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a22500182, createdName=1696533704_45270454, createdTime=Mon Jun 20 10:22:00 CST 2016, time=2016-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82698, encodeId=00e68269865, content=这个是短期的效果,长期效果呢,对于持续性房颤,节律控制优于心率控制哦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ebb1716792, createdName=黑心天使, createdTime=Mon Apr 25 11:23:00 CST 2016, time=2016-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79712, encodeId=2b4ae9712a2, content=文章值得一读!, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xwU6047w4GQZHmaJMe3cGxCqPS0x43a9R04dN3HrAn5diaR2N4pEwoibqiaiaA3m6ia3g3XbZXadIomlRa5WAvjSUHb/0, createdBy=93aa1715091, createdName=为啥子, createdTime=Tue Apr 19 21:05:00 CST 2016, time=2016-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78780, encodeId=5447e87805a, content=文章不错,看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160416/IMG5712156C1448C6881.jpg, createdBy=24d11713519, createdName=愤怒骆驼, createdTime=Sat Apr 16 18:39:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78733, encodeId=4803e8733d1, content=学习了,点赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a411691127, createdName=1de5aaa9m95(暂无匿称), createdTime=Sat Apr 16 14:27:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78618, encodeId=cfd6e8618d1, content=关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Fri Apr 15 21:44:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78553, encodeId=0942e85532d, content=文章不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Fri Apr 15 20:04:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78554, encodeId=dd42e855499, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Fri Apr 15 20:04:00 CST 2016, time=2016-04-15, status=1, ipAttribution=)]
    2016-04-25 黑心天使

    这个是短期的效果,长期效果呢,对于持续性房颤,节律控制优于心率控制哦。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2066831, encodeId=f1302066831d7, content=<a href='/topic/show?id=fe1a6106394' target=_blank style='color:#2F92EE;'>#术后房颤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61063, encryptionId=fe1a6106394, topicName=术后房颤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a22500182, createdName=1696533704_45270454, createdTime=Mon Jun 20 10:22:00 CST 2016, time=2016-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82698, encodeId=00e68269865, content=这个是短期的效果,长期效果呢,对于持续性房颤,节律控制优于心率控制哦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ebb1716792, createdName=黑心天使, createdTime=Mon Apr 25 11:23:00 CST 2016, time=2016-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79712, encodeId=2b4ae9712a2, content=文章值得一读!, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xwU6047w4GQZHmaJMe3cGxCqPS0x43a9R04dN3HrAn5diaR2N4pEwoibqiaiaA3m6ia3g3XbZXadIomlRa5WAvjSUHb/0, createdBy=93aa1715091, createdName=为啥子, createdTime=Tue Apr 19 21:05:00 CST 2016, time=2016-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78780, encodeId=5447e87805a, content=文章不错,看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160416/IMG5712156C1448C6881.jpg, createdBy=24d11713519, createdName=愤怒骆驼, createdTime=Sat Apr 16 18:39:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78733, encodeId=4803e8733d1, content=学习了,点赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a411691127, createdName=1de5aaa9m95(暂无匿称), createdTime=Sat Apr 16 14:27:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78618, encodeId=cfd6e8618d1, content=关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Fri Apr 15 21:44:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78553, encodeId=0942e85532d, content=文章不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Fri Apr 15 20:04:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78554, encodeId=dd42e855499, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Fri Apr 15 20:04:00 CST 2016, time=2016-04-15, status=1, ipAttribution=)]
    2016-04-19 为啥子

    文章值得一读!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2066831, encodeId=f1302066831d7, content=<a href='/topic/show?id=fe1a6106394' target=_blank style='color:#2F92EE;'>#术后房颤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61063, encryptionId=fe1a6106394, topicName=术后房颤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a22500182, createdName=1696533704_45270454, createdTime=Mon Jun 20 10:22:00 CST 2016, time=2016-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82698, encodeId=00e68269865, content=这个是短期的效果,长期效果呢,对于持续性房颤,节律控制优于心率控制哦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ebb1716792, createdName=黑心天使, createdTime=Mon Apr 25 11:23:00 CST 2016, time=2016-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79712, encodeId=2b4ae9712a2, content=文章值得一读!, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xwU6047w4GQZHmaJMe3cGxCqPS0x43a9R04dN3HrAn5diaR2N4pEwoibqiaiaA3m6ia3g3XbZXadIomlRa5WAvjSUHb/0, createdBy=93aa1715091, createdName=为啥子, createdTime=Tue Apr 19 21:05:00 CST 2016, time=2016-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78780, encodeId=5447e87805a, content=文章不错,看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160416/IMG5712156C1448C6881.jpg, createdBy=24d11713519, createdName=愤怒骆驼, createdTime=Sat Apr 16 18:39:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78733, encodeId=4803e8733d1, content=学习了,点赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a411691127, createdName=1de5aaa9m95(暂无匿称), createdTime=Sat Apr 16 14:27:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78618, encodeId=cfd6e8618d1, content=关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Fri Apr 15 21:44:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78553, encodeId=0942e85532d, content=文章不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Fri Apr 15 20:04:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78554, encodeId=dd42e855499, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Fri Apr 15 20:04:00 CST 2016, time=2016-04-15, status=1, ipAttribution=)]
    2016-04-16 愤怒骆驼

    文章不错,看看

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2066831, encodeId=f1302066831d7, content=<a href='/topic/show?id=fe1a6106394' target=_blank style='color:#2F92EE;'>#术后房颤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61063, encryptionId=fe1a6106394, topicName=术后房颤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a22500182, createdName=1696533704_45270454, createdTime=Mon Jun 20 10:22:00 CST 2016, time=2016-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82698, encodeId=00e68269865, content=这个是短期的效果,长期效果呢,对于持续性房颤,节律控制优于心率控制哦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ebb1716792, createdName=黑心天使, createdTime=Mon Apr 25 11:23:00 CST 2016, time=2016-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79712, encodeId=2b4ae9712a2, content=文章值得一读!, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xwU6047w4GQZHmaJMe3cGxCqPS0x43a9R04dN3HrAn5diaR2N4pEwoibqiaiaA3m6ia3g3XbZXadIomlRa5WAvjSUHb/0, createdBy=93aa1715091, createdName=为啥子, createdTime=Tue Apr 19 21:05:00 CST 2016, time=2016-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78780, encodeId=5447e87805a, content=文章不错,看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160416/IMG5712156C1448C6881.jpg, createdBy=24d11713519, createdName=愤怒骆驼, createdTime=Sat Apr 16 18:39:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78733, encodeId=4803e8733d1, content=学习了,点赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a411691127, createdName=1de5aaa9m95(暂无匿称), createdTime=Sat Apr 16 14:27:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78618, encodeId=cfd6e8618d1, content=关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Fri Apr 15 21:44:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78553, encodeId=0942e85532d, content=文章不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Fri Apr 15 20:04:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78554, encodeId=dd42e855499, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Fri Apr 15 20:04:00 CST 2016, time=2016-04-15, status=1, ipAttribution=)]
    2016-04-16 1de5aaa9m95(暂无匿称)

    学习了,点赞

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2066831, encodeId=f1302066831d7, content=<a href='/topic/show?id=fe1a6106394' target=_blank style='color:#2F92EE;'>#术后房颤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61063, encryptionId=fe1a6106394, topicName=术后房颤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a22500182, createdName=1696533704_45270454, createdTime=Mon Jun 20 10:22:00 CST 2016, time=2016-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82698, encodeId=00e68269865, content=这个是短期的效果,长期效果呢,对于持续性房颤,节律控制优于心率控制哦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ebb1716792, createdName=黑心天使, createdTime=Mon Apr 25 11:23:00 CST 2016, time=2016-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79712, encodeId=2b4ae9712a2, content=文章值得一读!, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xwU6047w4GQZHmaJMe3cGxCqPS0x43a9R04dN3HrAn5diaR2N4pEwoibqiaiaA3m6ia3g3XbZXadIomlRa5WAvjSUHb/0, createdBy=93aa1715091, createdName=为啥子, createdTime=Tue Apr 19 21:05:00 CST 2016, time=2016-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78780, encodeId=5447e87805a, content=文章不错,看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160416/IMG5712156C1448C6881.jpg, createdBy=24d11713519, createdName=愤怒骆驼, createdTime=Sat Apr 16 18:39:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78733, encodeId=4803e8733d1, content=学习了,点赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a411691127, createdName=1de5aaa9m95(暂无匿称), createdTime=Sat Apr 16 14:27:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78618, encodeId=cfd6e8618d1, content=关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Fri Apr 15 21:44:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78553, encodeId=0942e85532d, content=文章不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Fri Apr 15 20:04:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78554, encodeId=dd42e855499, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Fri Apr 15 20:04:00 CST 2016, time=2016-04-15, status=1, ipAttribution=)]
    2016-04-15 1de3b290m83(暂无匿称)

    关注

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2066831, encodeId=f1302066831d7, content=<a href='/topic/show?id=fe1a6106394' target=_blank style='color:#2F92EE;'>#术后房颤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61063, encryptionId=fe1a6106394, topicName=术后房颤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a22500182, createdName=1696533704_45270454, createdTime=Mon Jun 20 10:22:00 CST 2016, time=2016-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82698, encodeId=00e68269865, content=这个是短期的效果,长期效果呢,对于持续性房颤,节律控制优于心率控制哦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ebb1716792, createdName=黑心天使, createdTime=Mon Apr 25 11:23:00 CST 2016, time=2016-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79712, encodeId=2b4ae9712a2, content=文章值得一读!, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xwU6047w4GQZHmaJMe3cGxCqPS0x43a9R04dN3HrAn5diaR2N4pEwoibqiaiaA3m6ia3g3XbZXadIomlRa5WAvjSUHb/0, createdBy=93aa1715091, createdName=为啥子, createdTime=Tue Apr 19 21:05:00 CST 2016, time=2016-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78780, encodeId=5447e87805a, content=文章不错,看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160416/IMG5712156C1448C6881.jpg, createdBy=24d11713519, createdName=愤怒骆驼, createdTime=Sat Apr 16 18:39:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78733, encodeId=4803e8733d1, content=学习了,点赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a411691127, createdName=1de5aaa9m95(暂无匿称), createdTime=Sat Apr 16 14:27:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78618, encodeId=cfd6e8618d1, content=关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Fri Apr 15 21:44:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78553, encodeId=0942e85532d, content=文章不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Fri Apr 15 20:04:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78554, encodeId=dd42e855499, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Fri Apr 15 20:04:00 CST 2016, time=2016-04-15, status=1, ipAttribution=)]
    2016-04-15 李继凯

    文章不错

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2066831, encodeId=f1302066831d7, content=<a href='/topic/show?id=fe1a6106394' target=_blank style='color:#2F92EE;'>#术后房颤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61063, encryptionId=fe1a6106394, topicName=术后房颤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a22500182, createdName=1696533704_45270454, createdTime=Mon Jun 20 10:22:00 CST 2016, time=2016-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82698, encodeId=00e68269865, content=这个是短期的效果,长期效果呢,对于持续性房颤,节律控制优于心率控制哦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ebb1716792, createdName=黑心天使, createdTime=Mon Apr 25 11:23:00 CST 2016, time=2016-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79712, encodeId=2b4ae9712a2, content=文章值得一读!, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xwU6047w4GQZHmaJMe3cGxCqPS0x43a9R04dN3HrAn5diaR2N4pEwoibqiaiaA3m6ia3g3XbZXadIomlRa5WAvjSUHb/0, createdBy=93aa1715091, createdName=为啥子, createdTime=Tue Apr 19 21:05:00 CST 2016, time=2016-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78780, encodeId=5447e87805a, content=文章不错,看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160416/IMG5712156C1448C6881.jpg, createdBy=24d11713519, createdName=愤怒骆驼, createdTime=Sat Apr 16 18:39:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78733, encodeId=4803e8733d1, content=学习了,点赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a411691127, createdName=1de5aaa9m95(暂无匿称), createdTime=Sat Apr 16 14:27:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78618, encodeId=cfd6e8618d1, content=关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Fri Apr 15 21:44:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78553, encodeId=0942e85532d, content=文章不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Fri Apr 15 20:04:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78554, encodeId=dd42e855499, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Fri Apr 15 20:04:00 CST 2016, time=2016-04-15, status=1, ipAttribution=)]
    2016-04-15 李继凯

    值得关注

    0

相关资讯

四川大学华西医院成功实施我国首例突破心脏"禁区"手术

4月21日下午,川大华西医院宣布:在该院心脏大血管外科教授赁可带领下,医院的超声科、麻醉科、放射科及手术室的多学科协助,成功实施了我国首例突破心脏“禁区”的手术—经皮穿刺左心室入路的心脏手术,手术取得圆满成功,患者将于明日出院。43岁的宜宾人郑女士(化名)三年前因为风湿性心脏病,在当地医院接受了二尖瓣置换术。然而,手术第二年,曾经莫名的疲劳感又开始回到她身上,甚至还出现了呼吸困难、胸痛、尿少的情况

刀尖,在心脏上起舞

用惊心动魄来形容心脏手术一点也不为过,阜外心血管病医院里,“刀尖在心脏上起舞”每天都在上演,考验医生技术的同时,也为患者带来生的希望。一场“常规”手术这是一个普通的上午,阜外医院的电教室里座无虚席,参加培训的医生们,神情专注地盯着大屏幕上的手术演示。手术室里,医务人员们正在紧张忙碌着,他们在患者胸壁上开几个小孔,这几个小孔就是打通外界与心脏的通道,通过这几个小孔,一台复杂的心脏手术在几乎看不到

NEJM:输血时红细胞越新鲜越好吗?

先前有观察性研究表明,输注贮存超过2-3周的红细胞,会使严重的致命的不良反应事件发生风险增加。对于外科手术病人,因为其输血的可能性更大,特别容易受到输血不良反应的影响。

NEJM:心脏手术的远程缺血预处理效果

远程缺血预处理(RIPC)被报道为减少心脏手术缺血再灌注损伤的生物标志物,但对临床结果的不确定性仍然存在。研究人员进行了一项前瞻性,双盲,多中心,随机对照试验,涉及的参与者为那些在异丙酚进行全身麻醉条件下,被择期接受心肺转流术的心脏外科手术成年患者。该试验比较了上肢RIPC假干预的结果。主要终点到出院时心肌梗死,中风或急性肾功能衰竭的复合型死亡。次要终点包括在90天时任何单一组分主要终点的发生。总

NEJM:远端缺血预处理能否改善心脏手术预后?

据报道心脏手术的患者接受远程缺血预处理(RIPC)后可减少缺血和再灌注损伤,但并没有很多临床证据来支持这一结果。研究人员进行了一项前瞻性、双盲、多中心、随机对照试验,患者在麻醉后接受上肢远端缺血预处理或假手术处理。主要终点是患者出院时死亡,心肌梗死,中风,或急性肾功能衰竭复合事件。次要终点是90天时主要终点事件发生率包括任何单个事件的发生。共有1403名患者进行了随机化治疗,对1385名患者进行了

JAMA:接受心脏手术的患者是否应接受储存血液成分?

在一些大型手术中,患者通常要输注一些红细胞以弥补丢失的血液成分。然而,对于要进行心脏手术的患者,是否应该为其输注储存较久的血液成分,研究人员争执不休。瑞典卡罗林斯卡医学院研究人员进行的一项发表在JAMA的研究表明,储存在14-42天之间的血液成分都可安全使用。 血中红细胞最久储存时长为42天,但一般为术中患者输注的红细胞储存时长平均是18天。红细胞在血液循环中携带氧气,并为全身供氧。若储存时间较久

Baidu
map
Baidu
map
Baidu
map